John Doe
John Doe@username
Read More
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
John Doe
John Doe@username
Read More
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
John Doe
John Doe@username
Read More
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Previous
Next

Це заголовок

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Study of mental disorders prevalence among opioid agonist therapy patients. Opioid agonist therapy (OAT): Barriers to the assessment of access to OAT and evaluation of service delivery models in the context of their effectiveness.

-

The term of realization

07.06.2021 – 31.12.2022
08.02.2022 – 29.03.2022

Principal Investigator

Kostiantyn Dumchev

Funded by

Global Fund to Fight AIDS,
Tuberculosis & Malaria

The aim of the project

  1. To study the prevalence of mental disorders among people with mental and behavioral disorders due to opioid use who are on the OAT.
  2. To identify key barriers to accessing tpi agonist therapy in Ukraine for injecting drug users.

Goals and objectives

  1. To study the prevalence of mental disorders among OAT patients.
  2. To identify which mental disorders are most common among OAT patients.
Scroll to Top